Patent · US Active

Compositions of asymmetric interfering RNA and uses thereof

US10927376B2 · kind B2 · utility

1Cited by
6References
34Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 20, 2019
Grant dateFeb 23, 2021
Priority date
Expiry dateFeb 20, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2330/51
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides asymmetrical duplex RNA molecules that are capable of effecting sequence-specific gene silencing. The RNA molecule comprises a first strand and a second strand. The first strand is longer than the second strand. The RNA molecule comprises a double-stranded region formed by the first strand and the second strand, and two ends independently selected from the group consisting of 5′-overhang, 3′-overhang, and blunt end. The RNA molecules of the present invention can be used as research tools and/or therapeutics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.